Formic Acid

Formic Acid

SCHEMBL19149698

O=C(C1C2CC3CC(C2)CC1C3)N1CCN(Cc2ccccc2)CC1.O=CO

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.55
▸ ALDH1A1 P00352 6/20 0.54
▸ KMT2A Q03164 5/20 0.54
▸ MEN1 O00255 4/20 0.54
▸ TSHR P16473 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ HTT P42858 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ LMNA P02545 2/20 0.53
▸ POLB P06746 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.48
▸ CYP2C19 P33261 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ GPR183 P32249 1/20 0.47
▸ CXCR3 P49682 1/20 0.47
▸ FAAH O00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19172946 0.95 HSD11B1 (0.60) HSD11B1ALDH1A1KMT2AMEN1TSHR
SCHEMBL19173469 0.85 HSD11B1 (0.52) HSD11B1ALDH1A1KMT2AMEN1TSHR
SCHEMBL5080239 0.74 KMT2A (0.78) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL611401 0.73 ALDH1A1 (0.68) HSD11B1ALDH1A1KMT2AMEN1TSHR
SCHEMBL12443568 0.72 TFPI2 (0.50) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL9510221 0.72 ALDH1A1 (0.62) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL1143256 0.72 SIGMAR1 (0.60) HSD11B1ALDH1A1KMT2AMEN1TSHR
SCHEMBL13556913 0.72 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL2850013 0.71 ALDH1A1 (0.70) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL10825084 0.71 ALDH1A1 (0.70) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3405183-A1 ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTION Arisan Therapeutics Inc. (US) 2018-11-28 — — EP disclosed
WO-2017127306-A1 ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTION ARISAN THERAPEUTICS (US) 2017-07-27 — — WO disclosed
Send feedback